Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation

Dimitrios N. Samonakis, Christos K. Triantos, Ulrich Thalheimer, Alberto Quaglia, Gioacchino Leandro, Rosângela Teixeira, George V. Papatheodoridis, Caroline A. Sabin, Nancy Rolando, Susan Davies, Amar P. Dhillon, Paul Griffiths, Vincent Emery, Daivd W. Patch, B. R. Davidson, Keith Rolles, Andrew K. Burroughs

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears to be worsening in recent years. Donor age has been suggested as a cause. However, it is not clear if early and/or late mortality is affected and whether donor age is a key factor, as opposed to changes in immunosuppression. The aim of this study was to assess impact of donor age and other factors with respect to the severity of HCV recurrence posttransplant. A consecutive series of 193 HCV cirrhotic patients were transplanted with cadaveric donors, median age 41.5 years (13-73) and median follow-up of 38 months (1-155). Donor age and other factors were examined in a univariate/multivariate model for early/late survival, as well as fibrosis (grade 4 or more, Ishak score) with regular biopsies, 370 in total, from 1 year onwards. Results of the study indicated that donor age influenced only short-term (3 months) survival, with no significant effect on survival after 3 months. Known HCC independently adversely affected survival, as did the absence of maintenance azathioprine. Severe fibrosis (stage ≥ 4) in 51 patients was related to neither donor age nor year of transplantation, but it was independently associated with combined biochemical/histological hepatitis flare (OR 2.9, 95% CI 1.76-4.9) whereas maintenance steroids were protective (OR 0.4, 95% CI 0.23-0.83). In conclusion, in this cohort donor age did not influence late mortality in HCV transplanted cirrhotic patients or development of severe fibrosis, which was related to absence of maintenance steroids and a hepatitis flare. Maintenance azathioprine gave survival advantage.

Original languageEnglish
Pages (from-to)386-395
Number of pages10
JournalLiver Transplantation
Volume11
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Liver Transplantation
Tissue Donors
Recurrence
Survival
Maintenance
Fibrosis
Age Factors
Azathioprine
Hepatitis
Steroids
Mortality
Immunosuppression
Transplantation
Biopsy

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Samonakis, D. N., Triantos, C. K., Thalheimer, U., Quaglia, A., Leandro, G., Teixeira, R., ... Burroughs, A. K. (2005). Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transplantation, 11(4), 386-395. https://doi.org/10.1002/lt.20344

Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation. / Samonakis, Dimitrios N.; Triantos, Christos K.; Thalheimer, Ulrich; Quaglia, Alberto; Leandro, Gioacchino; Teixeira, Rosângela; Papatheodoridis, George V.; Sabin, Caroline A.; Rolando, Nancy; Davies, Susan; Dhillon, Amar P.; Griffiths, Paul; Emery, Vincent; Patch, Daivd W.; Davidson, B. R.; Rolles, Keith; Burroughs, Andrew K.

In: Liver Transplantation, Vol. 11, No. 4, 04.2005, p. 386-395.

Research output: Contribution to journalArticle

Samonakis, DN, Triantos, CK, Thalheimer, U, Quaglia, A, Leandro, G, Teixeira, R, Papatheodoridis, GV, Sabin, CA, Rolando, N, Davies, S, Dhillon, AP, Griffiths, P, Emery, V, Patch, DW, Davidson, BR, Rolles, K & Burroughs, AK 2005, 'Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation', Liver Transplantation, vol. 11, no. 4, pp. 386-395. https://doi.org/10.1002/lt.20344
Samonakis, Dimitrios N. ; Triantos, Christos K. ; Thalheimer, Ulrich ; Quaglia, Alberto ; Leandro, Gioacchino ; Teixeira, Rosângela ; Papatheodoridis, George V. ; Sabin, Caroline A. ; Rolando, Nancy ; Davies, Susan ; Dhillon, Amar P. ; Griffiths, Paul ; Emery, Vincent ; Patch, Daivd W. ; Davidson, B. R. ; Rolles, Keith ; Burroughs, Andrew K. / Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation. In: Liver Transplantation. 2005 ; Vol. 11, No. 4. pp. 386-395.
@article{0298a5070f7a45ffa44c51f932b6ad87,
title = "Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation",
abstract = "In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears to be worsening in recent years. Donor age has been suggested as a cause. However, it is not clear if early and/or late mortality is affected and whether donor age is a key factor, as opposed to changes in immunosuppression. The aim of this study was to assess impact of donor age and other factors with respect to the severity of HCV recurrence posttransplant. A consecutive series of 193 HCV cirrhotic patients were transplanted with cadaveric donors, median age 41.5 years (13-73) and median follow-up of 38 months (1-155). Donor age and other factors were examined in a univariate/multivariate model for early/late survival, as well as fibrosis (grade 4 or more, Ishak score) with regular biopsies, 370 in total, from 1 year onwards. Results of the study indicated that donor age influenced only short-term (3 months) survival, with no significant effect on survival after 3 months. Known HCC independently adversely affected survival, as did the absence of maintenance azathioprine. Severe fibrosis (stage ≥ 4) in 51 patients was related to neither donor age nor year of transplantation, but it was independently associated with combined biochemical/histological hepatitis flare (OR 2.9, 95{\%} CI 1.76-4.9) whereas maintenance steroids were protective (OR 0.4, 95{\%} CI 0.23-0.83). In conclusion, in this cohort donor age did not influence late mortality in HCV transplanted cirrhotic patients or development of severe fibrosis, which was related to absence of maintenance steroids and a hepatitis flare. Maintenance azathioprine gave survival advantage.",
author = "Samonakis, {Dimitrios N.} and Triantos, {Christos K.} and Ulrich Thalheimer and Alberto Quaglia and Gioacchino Leandro and Ros{\^a}ngela Teixeira and Papatheodoridis, {George V.} and Sabin, {Caroline A.} and Nancy Rolando and Susan Davies and Dhillon, {Amar P.} and Paul Griffiths and Vincent Emery and Patch, {Daivd W.} and Davidson, {B. R.} and Keith Rolles and Burroughs, {Andrew K.}",
year = "2005",
month = "4",
doi = "10.1002/lt.20344",
language = "English",
volume = "11",
pages = "386--395",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Immunosuppresion and donor age with respect to severity of HCV recurrence after liver transplantation

AU - Samonakis, Dimitrios N.

AU - Triantos, Christos K.

AU - Thalheimer, Ulrich

AU - Quaglia, Alberto

AU - Leandro, Gioacchino

AU - Teixeira, Rosângela

AU - Papatheodoridis, George V.

AU - Sabin, Caroline A.

AU - Rolando, Nancy

AU - Davies, Susan

AU - Dhillon, Amar P.

AU - Griffiths, Paul

AU - Emery, Vincent

AU - Patch, Daivd W.

AU - Davidson, B. R.

AU - Rolles, Keith

AU - Burroughs, Andrew K.

PY - 2005/4

Y1 - 2005/4

N2 - In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears to be worsening in recent years. Donor age has been suggested as a cause. However, it is not clear if early and/or late mortality is affected and whether donor age is a key factor, as opposed to changes in immunosuppression. The aim of this study was to assess impact of donor age and other factors with respect to the severity of HCV recurrence posttransplant. A consecutive series of 193 HCV cirrhotic patients were transplanted with cadaveric donors, median age 41.5 years (13-73) and median follow-up of 38 months (1-155). Donor age and other factors were examined in a univariate/multivariate model for early/late survival, as well as fibrosis (grade 4 or more, Ishak score) with regular biopsies, 370 in total, from 1 year onwards. Results of the study indicated that donor age influenced only short-term (3 months) survival, with no significant effect on survival after 3 months. Known HCC independently adversely affected survival, as did the absence of maintenance azathioprine. Severe fibrosis (stage ≥ 4) in 51 patients was related to neither donor age nor year of transplantation, but it was independently associated with combined biochemical/histological hepatitis flare (OR 2.9, 95% CI 1.76-4.9) whereas maintenance steroids were protective (OR 0.4, 95% CI 0.23-0.83). In conclusion, in this cohort donor age did not influence late mortality in HCV transplanted cirrhotic patients or development of severe fibrosis, which was related to absence of maintenance steroids and a hepatitis flare. Maintenance azathioprine gave survival advantage.

AB - In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears to be worsening in recent years. Donor age has been suggested as a cause. However, it is not clear if early and/or late mortality is affected and whether donor age is a key factor, as opposed to changes in immunosuppression. The aim of this study was to assess impact of donor age and other factors with respect to the severity of HCV recurrence posttransplant. A consecutive series of 193 HCV cirrhotic patients were transplanted with cadaveric donors, median age 41.5 years (13-73) and median follow-up of 38 months (1-155). Donor age and other factors were examined in a univariate/multivariate model for early/late survival, as well as fibrosis (grade 4 or more, Ishak score) with regular biopsies, 370 in total, from 1 year onwards. Results of the study indicated that donor age influenced only short-term (3 months) survival, with no significant effect on survival after 3 months. Known HCC independently adversely affected survival, as did the absence of maintenance azathioprine. Severe fibrosis (stage ≥ 4) in 51 patients was related to neither donor age nor year of transplantation, but it was independently associated with combined biochemical/histological hepatitis flare (OR 2.9, 95% CI 1.76-4.9) whereas maintenance steroids were protective (OR 0.4, 95% CI 0.23-0.83). In conclusion, in this cohort donor age did not influence late mortality in HCV transplanted cirrhotic patients or development of severe fibrosis, which was related to absence of maintenance steroids and a hepatitis flare. Maintenance azathioprine gave survival advantage.

UR - http://www.scopus.com/inward/record.url?scp=20244366386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20244366386&partnerID=8YFLogxK

U2 - 10.1002/lt.20344

DO - 10.1002/lt.20344

M3 - Article

VL - 11

SP - 386

EP - 395

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 4

ER -